Stay informed about the latest diabetes news and research, including medical discoveries, treatment developments, clinical studies, technology and emerging health insights.
The Danish drugmaker has expanded its diabetes treatment range in Thailand, while preparing specialist training as competition intensifies in the GLP-1 medicines market. Novo Nordisk has introduced a higher-dose semaglutide option in Thailand, widening the range of treatments available to…
Originally developed for diabetes, GLP-1 medicines are becoming a cultural and commercial infrastructure spanning body image, telehealth and long-term healthcare costs. GLP-1 drugs have moved from specialist medicine to a cultural and commercial force, reshaping conversations about weight, appetite and…
Specialists say taking GLP-1 drugs for a wedding or other event can cause muscle loss, nutritional deficiencies and severe side effects when treatment is not medically supervised. GLP-1 medicines have become one of the most talked-about tools in modern metabolic…
Insu Therapeutics has secured a US patent allowance for its buccal delivery platform, but its needle-free insulin and semaglutide treatments remain investigational and require clinical and regulatory approval. Victory Square Technologies said Insu Therapeutics has received a notice of allowance…
A new American College of Lifestyle Medicine consensus statement says group-based consultations could widen access and support behaviour change, while acknowledging that evidence on their effectiveness remains mixed. The American College of Lifestyle Medicine has issued an expert consensus statement…
People with the highest intake of Neu5Gc, a sugar found mainly in beef and lamb, had a 63% higher risk of developing type 2 diabetes, but researchers stressed that the observational findings do not prove cause and effect. New research…
A recent study highlights that body-shape measures focusing on fat distribution, particularly the conicity index, could be promising tools for early detection of diabetic peripheral neuropathy, ahead of traditional BMI assessments. A new study published in Dove Medical Press suggests…
Nicole Gourley brings over 18 years of experience to her new role at the National Diabetes Trust, aiming to strengthen the organisation’s support for Diabetes Canada’s wider mission and expand its reach across Canada. National Diabetes Trust has appointed Nicole…
With over 40 million adults living with diabetes in the US, health authorities emphasise the importance of recognising symptoms and timely screening to prevent complications amidst rising prevalence and risk factors. More than 40 million adults in the United States…
Researchers at KAIST have created a battery-free, wireless smart patch that visually and quantitatively monitors diabetic foot ulcers, potentially transforming wound management with real-time, non-invasive data via a colour-changing dressing and smartphone interface. Researchers at the Korea Advanced Institute of…
A new guide highlights the importance of recognising subtle foot problems in elderly individuals, which can signal broader mobility decline and threaten independence if left untreated. A guide published by My Stay At Home Adventures argues that foot problems in…
Brazil’s health regulator, Anvisa, has ordered the suspension of multiple insulin, tirzepatide, and peptide products sold without proper authorisation, targeting unlicensed online sales and unregistered manufacturers amidst ongoing regulatory crackdowns. Brazil’s health regulator has ordered the suspension of sales of…
